Literature DB >> 21455638

Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.

Pedro Pimentel-Nunes1, Luís Afonso, Paula Lopes, Roberto Roncon-Albuquerque, Nádia Gonçalves, Rui Henrique, Luís Moreira-Dias, Adelino F Leite-Moreira, Mário Dinis-Ribeiro.   

Abstract

TLRs are important innate immunity receptors. Even though TLR2, 4 and 5 appear to be important for Helicobacter pylori (HP) recognition, their role in the evolution of gastritis to more advanced lesions is still unknown. To compare the expression of TLR2, 4 and 5 in normal gastric mucosa, HP+ gastritis, intestinal metaplasia, dysplasia and adenocarcinoma. Immunohistochemistry for TLR2, 4 and 5 was performed with anti-TLR2-TLR4-TLR5 antibodies in 117 histological samples of normal gastric mucosa (n = 22), HP+ gastritis (n = 20), intestinal metaplasia (n = 33), dysplasia (mucosectomy specimens, n = 20) and intestinal type adenocarcinoma (surgery specimens,n = 22); quantification of expression was performed independently by two pathologists taking into account the percentage of positive epithelial cells and the degree of expression (zero to three score). A statistically significant trend for progressive increase of TLRs expression from normal mucosa to gastric dysplasia was found (mean expression: normal mucosa 0.1; gastritis 1.0; metaplasia 2.2; dysplasia 2.8, p < 0.01). All dysplasia samples presented more than 90% positive epithelial cells with strong expression (2.8;95%CI2.7-3). There was less TLRs expression in carcinomas (TLR2:1.0; TLR4:2.0 and TLR5:1.2, p < 0.05) when compared with dysplasia, with TLR4 being more expressed than TLR2 and 5 in these lesions (p = 0.03). A score of all markers' expression of eight leads to a low (4%) false positive rate in patients with precancerous conditions. Progression of gastric lesions associated with gastric carcinogenesis is associated with increased TLRs expression. Gastric dysplasia presents a high level of TLRs expression, suggesting that these receptors may play a role in adenocarcinoma development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455638     DOI: 10.1007/s12253-011-9368-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  43 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

Review 2.  Pleiotropic function of Toll-like receptors.

Authors:  Tsuneyasu Kaisho; Shizuo Akira
Journal:  Microbes Infect       Date:  2004-12       Impact factor: 2.700

3.  Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection.

Authors:  T Kawahara; Y Kuwano; S Teshima-Kondo; T Kawai; T Nikawa; K Kishi; K Rokutan
Journal:  J Med Invest       Date:  2001-08

4.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

5.  Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis.

Authors:  Shunji Ishihara; Mohammad Azharul Karim Rumi; Yasunori Kadowaki; Cesar Francisco Ortega-Cava; Takafumi Yuki; Nagisa Yoshino; Youichi Miyaoka; Hideaki Kazumori; Norihisa Ishimura; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

6.  Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5.

Authors:  Sae Kyung Lee; Allison Stack; Elena Katzowitsch; Shin Ichi Aizawa; Sebastian Suerbaum; Christine Josenhans
Journal:  Microbes Infect       Date:  2003-12       Impact factor: 2.700

7.  Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation.

Authors:  Ya Jen Chang; Ming Shiang Wu; Jaw Town Lin; Bor Shyang Sheu; Tatsushi Muta; Hiroyasu Inoue; Ching-Chow Chen
Journal:  Mol Pharmacol       Date:  2004-09-29       Impact factor: 4.436

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells.

Authors:  Michael F Smith; Anastasia Mitchell; Guolian Li; Song Ding; Ann Marie Fitzmaurice; Kieran Ryan; Sheila Crowe; Joanna B Goldberg
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

View more
  28 in total

1.  Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior.

Authors:  Olli Helminen; Heikki Huhta; Joni Leppänen; Joonas H Kauppila; Heikki Takala; Petri P Lehenkari; Juha Saarnio; Tuomo J Karttunen
Journal:  Virchows Arch       Date:  2016-07-09       Impact factor: 4.064

2.  TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?

Authors:  Myriem Boufraqech; Catsim Fassassi; Electron Kebebew
Journal:  Endocrine       Date:  2012-11-09       Impact factor: 3.633

Review 3.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

4.  Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.

Authors:  A C West; K Tang; H Tye; L Yu; N Deng; M Najdovska; S J Lin; J J Balic; E Okochi-Takada; P McGuirk; B Keogh; W McCormack; P S Bhathal; M Reilly; M Oshima; T Ushijima; P Tan; B J Jenkins
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

Review 5.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

6.  High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.

Authors:  Hui Zhou; Jian-hua Chen; Jun Hu; Yong-zhong Luo; Fang Li; Ling Xiao; Mei-zuo Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-19       Impact factor: 4.553

Review 7.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

8.  Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis.

Authors:  Joonas H Kauppila; Antti E Mattila; Tuomo J Karttunen; Tuula Salo
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

Review 9.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

10.  IgG4+ plasma cell infiltration is correlated with the development of inflammatory bowel disease and can be regulated by TLR-4.

Authors:  Xiaowei Chen; Wenwen Sun; Risheng Lin; Zhiming Huang; Weichang Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.